Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Early Phase 1
1(33.3%)
3Total
N/A(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07558148Not ApplicableRecruiting

OCD LIFU Target Engagement

Role: collaborator

NCT06461221Early Phase 1Withdrawn

tFUS to Enhance Alertness and Performance

Role: collaborator

NCT05895474Not ApplicableCompleted

Safety Assessment of Central Medial Thalamus Stimulation Using Transcranial Focused Ultrasound

Role: collaborator

All 3 trials loaded